Innosuisse - Swiss Innovation Agency
11
2
3
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
9.1%
1 terminated/withdrawn out of 11 trials
85.7%
-0.8% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Menstrual Cycle Mapping While Using Closed-Loop Insulin Delivery
Role: collaborator
SwissNeuroRehab - HDHI
Role: collaborator
DreaMS - Validation Study 1
Role: collaborator
Hospital@Home: Telemedical Care After Inpatient Hospital Stay
Role: collaborator
Validation of a Risk Assessment Model for Postoperative Delirium Based on Artificial Intelligence
Role: collaborator
Nanomotion-based Resistell AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia and/or Sepsis
Role: collaborator
Development of an Early Warning Score for Detecting the Deterioration of a Patients' General Condition in an Acute Hospital
Role: collaborator
Development of an Automatically Generated and Wearable-based Early Warning System
Role: collaborator
ExerG: Video Game-based Physical Cognitive Training for Patients: a Usability Study
Role: collaborator
Self-modulated Functional Electrical Stimulation in Chronic Stroke Patients With Severe and Moderate Upper Limb Paresis
Role: collaborator
The Detection of Heat Stress by Assessing Individual Body Responses to Heat (Heat Strain) in Young and Healthy Non-athlete Participants
Role: collaborator
All 11 trials loaded